Sinovac Biotech Ltd.

SVA · NASDAQ
Analyze with AI
6/30/2024
12/31/2023
6/30/2023
12/31/2022
Assets
Cash & Equivalents$1,072,350$1,270,131$1,643,026$4,278,124
Short-Term Investments$9,502,185$9,953,042$9,425,778$7,034,569
Receivables$404,718$450,722$500,440$609,489
Inventory$153,524$139,874$182,735$180,719
Other Curr. Assets$2,779$5,166$3,734$8,253
Total Curr. Assets$11,148,280$11,830,556$11,769,025$12,126,396
Property Plant & Equip (Net)$954,298$1,031,914$1,122,930$1,173,279
Goodwill$0$0$0$0
Intangibles$70,760$74,060$74,272$79,514
Long-Term Investments$681,345$684,285$657,767$661,440
Tax Assets$32,798$29,790$98,688$71,118
Other NC Assets$9,456$7,369$2,328$2,821
Total NC Assets$1,748,657$1,827,418$1,955,985$1,988,172
Other Assets$0$0$0$0
Total Assets$12,896,937$13,657,974$13,725,010$14,114,568
Liabilities
Payables$641,579$17,291$819,530$19,825
Short-Term Debt$179,349$76,089$205,277$4,651
Tax Payable$28,720$41,258$0$256,640
Deferred Revenue$6,978$21,713$19,285$33,075
Other Curr. Liab.$0$0$0$0
Total Curr. Liab.$978,451$1,147,904$1,189,629$1,091,635
LT Debt$130,320$177,817$10,989$11,513
Deferred Rev, NC$6,179$200$6,548$4,477
Deferred Tax Liab, NC$262,174$263,711$239,029$241,526
Other NC Liab.$429$439$630$240
Total NC Liab.$411,490$481,438$298,125$310,272
Other Liabilities$0$5,865$0$0
Cap. Leases$14,839$45,077$46,919$58,509
Total Liabilities$1,389,941$1,635,207$1,487,754$1,401,907
Equity
Pref Stock$15$15$15$15
Common Stock$100$100$100$100
Retained Earnings$7,107,644$7,118,516$7,239,947$7,225,987
AOCI$1,000,169$1,049,529$883,551$1,154,737
Other Equity$0$0$0$0
Total Equity$8,649,186$8,709,418$8,664,871$8,921,421
Supplemental Information
Minority Interest$2,857,810$3,313,349$3,572,385$3,791,240
Total Liab. & Tot. Equity$12,896,937$13,657,974$13,725,010$14,114,568
Net Debt-$762,681-$1,016,225-$1,426,760-$4,261,960
Sinovac Biotech Ltd. (SVA) Financial Statements & Key Stats | AlphaPilot